| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034090 |
| Receipt No. | R000038861 |
| Official scientific title of the study | Clinical investigation of Glucose Intolerance in Patients with Pheochromocytoma |
| Date of disclosure of the study information | 2018/09/11 |
| Last modified on | 2018/09/11 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Clinical investigation of Glucose Intolerance in Patients with Pheochromocytoma | |
| Title of the study (Brief title) | Clinical investigation of Glucose Intolerance in Patients with Pheochromocytoma | |
| Region |
|
|
| Condition | ||
| Condition | pheochromocytoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effects of pheochrmocytoma with regard to Glucose Intolerance. |
| Basic objectives2 | Others |
| Basic objectives -Others | To assess glycemic parameters in patients with pheochrmocytoma before and after surgery. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Investigation of the association between the change of HOMA-beta and HOMA-R, and that of urinary levels of metanephrine/normetanephrine before and after surgery. |
| Key secondary outcomes | Investigation of changes of fasting plasma glucose and HbA1c before and after surgery. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All individuals with pheochromocytoma who were admitted, diagnosed and who underwent surgery at Fukuoka University Chikushi Hospital (Fukuoka, Japan) from April 2014 to March 2018 | |||
| Key exclusion criteria | none | |||
| Target sample size | 12 | |||
| Research contact person | |
| Name of lead principal investigator | Kunihisa Kobayashi |
| Organization | Fukuoka University Chikushi Hospital |
| Division name | Department of Endocrinology and Diabetes Mellitus |
| Address | 1-1-1, Zokumyoin, Chikushino, Fukuoka |
| TEL | 092-921-1011 |
| nihisak@fukuoka-u.ac.jp | |
| Public contact | |
| Name of contact person | Ichiro Abe |
| Organization | Fukuoka University Chikushi Hospital |
| Division name | Department of Endocrinology and Diabetes Mellitus |
| Address | 1-1-1, Zokumyoin, Chikushino, Fukuoka |
| TEL | 092-921-1011 |
| Homepage URL | |
| abe1ro@fukuoka-u.ac.jp | |
| Sponsor | |
| Institute | Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Supported by grants from MSD Corporation and Mitsubishi Tanabe Pharma Corporation. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福岡大学筑紫病院(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We reveal the mechanism of glucose intolerance on pheochromocytoma by investigating glycemic parameters before and after surgery, and investigated the association between the change of parameters of HOMA-beta and HOMA-R, and that of urinary levels of metanephrine/normetanephrine before and after surgery. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038861 |